CRPS Clinical Trial – Participants Needed
We have been asked to share this CRPS clinical trial by MAC Clinical Research as they are looking for participants for their Complex Regional Pain Syndrome (CRPS) clinical trial. Are you interested? If so read on.
Unfortunately as of the end of June 2019, MAC Research has pulled out of the CRPS clinical trial in Neridronate. St Pancras Research have also pulled the trial. Unfortunately it would seem that at the first 3 month study of the results, the patients involved in the trial could find no difference between the placebo and the drug being trialled. As soon as we learn more we will let you know.
Clinical Trial in Complex Regional Pain Syndrome at MAC Clinical Research
At MAC Clinical Research, we are known for our expertise and experience in pain research and for this reason we have been selected to be involved in many studies into chronic pain disorders. In addition to running clinical trials in new forms of medications, our experts have also been involved in the successful design of clinical studies involving chronic pain.
Currently at MAC we are running a clinical trial for patients with Complex Regional Pain Syndrome. The treatment being tested is called neridronic acid and will be administered as an intravenous infusion. It belongs to a family of drugs called bisphosphonates which have been used to treat a variety of diseases for the past 40 years.
The purpose of this clinical trial is to further evaluate whether neridronic acid is effective in reducing pain in patients with CRPS. In addition, this trial will investigate the safety of neridronic acid in patients with CRPS and its effect on other symptoms of the condition.
Our team consists of a diverse range of staff; from doctors, research nurses; to study coordinators, and clinical trials assistants. During the study the team will closely monitor the level of markers in the blood which indicate changes to bones and measure possible inflammation. Throughout a patient’s participation in a study tests and medications will be given at no cost. In addition, travel expenses will be covered.
This study will run at our Clinics in Manchester, Blackpool, Liverpool, Leeds, Barnsley, Cannock and Teesside. Participants will be enrolled onto the study for 14 months, with between 13 and 17 visits into clinic during this time period.
If you would like to learn more about our background with pain disorders, or you would be interested in taking part in our clinical trials then please contact 0800 633 5507 or text PAIN to 81025 or visit www.researchforyou.co.uk/pain to discuss how you can get involved.
A full description of the study will be given before you decide to take part.
Last Updated: 01/07/2019